62 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
beneficially owned by them, subject to community property laws, where applicable.
Shares Beneficially Owned
Name and address of beneficial owner (1)
Number
8-K
AKRO
Akero Therapeutics Inc
4 Mar 24
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
7:55am
to the investment community slide presentations to provide updates and summaries of its business. A copy of its HARMONY Study slide presentation
8-K
nyxsvqpqn558av65
10 Oct 23
Regulation FD Disclosure
8:04am
8-K
et57pju 1ma28
5 Jun 23
Results of Operations and Financial Condition
8:05am
8-K
EX-99.1
6iqayloyx v7u5mb
15 May 23
Akero Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
7:19am
8-K
80p ubp1r
13 Sep 22
Regulation FD Disclosure
9:07am
8-K
EX-99.1
ecjv21w5qofjc6
13 Sep 22
Regulation FD Disclosure
9:07am
8-K
328697l1i
8 Jun 22
Regulation FD Disclosure
9:06am